CMS强制液体管理在合并液体过载的脓毒症患者中的结局:系统评价与Meta分析
该系统评价与Meta分析检索PubMed和Scopus至2021年11月5日,纳入5项观察性研究、共5804例合并CHF和/或ESRD的脓毒症患者,其中5260例(91%)接受非积极液体复苏。随机效应Meta分析显示,积极液体复苏与全因死亡率无显著增加相关(OR 1.42,95%CI 0.88-2.3,P=0.15,I2=35%);液体量与血管活性药需求、有创机械通气、ICU和/或住院时间等结局均无统计学关联。作者认为,限制性液体组较标准液体组有结局更好的趋势,但因仅纳入5项观察性研究,仍需更多研究指导该人群的最佳液体量和速度。
要点
- 合并CHF和/或ESRD的脓毒症休克患者中,积极液体复苏(≥30 ml/kg)与全因死亡率无显著增加相关(OR 1.42,95%CI 0.88-2.3,P=0.15)。
- 该Meta分析纳入5项观察性研究、5804例患者,其中5260例(91%)接受非积极液体复苏。
- 液体量与血管活性药需求、有创机械通气、ICU和/或住院时间均无统计学关联。
- 限制性液体组较标准液体组有结局更好的趋势,但未达统计学显著。
- 作者认为,因仅纳入5项观察性研究,仍需更多研究指导该人群的最佳液体量和速度。
适用人群与场景
- 合并充血性心力衰竭(CHF)和/或终末期肾病(ESRD)的脓毒症休克患者。
研究设计与关键结果
- 研究类型:系统评价与Meta分析,检索PubMed和Scopus至2021年11月5日,纳入5项观察性研究,共5804例合并CHF和/或ESRD的脓毒症患者,其中5260例(91%)接受非积极液体复苏。
- 主要终点:全因死亡率,积极液体复苏与死亡率无显著增加相关(OR 1.42,95%CI 0.88-2.3,P=0.15,I2=35%)。
- 次要终点:液体量与血管活性药需求、有创机械通气、ICU和/或住院时间均无统计学关联。
- 限制性液体组较标准液体组有结局更好的趋势,但未达统计学显著。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析,仅纳入5项观察性研究。
- 局限:仅纳入5项观察性研究;作者指出需更多研究指导该人群的最佳液体量和速度。
对床旁实践的改变
- 作者认为,在合并CHF和/或ESRD的脓毒症休克患者中,≥30 ml/kg液体复苏与死亡率无显著增加相关,但限制性液体策略有结局更好的趋势。
- 作者指出,因仅纳入5项观察性研究,仍需更多研究指导该人群的最佳液体量和速度。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: The outcomes of large-volume IVF administration to septic shock patients with comorbid congestive heart failure (CHF) and/or end-stage renal disease (ESRD) are uncertain and widely debated in the existing literature. Despite this uncertainty, CMS continues to recommend that 30 ml/kg of an intravenous crystalloid solution be administered to patients in septic shock starting within 3 h of presentation. We performed a systematic review and meta-analysis to assess the relationship between adherence to this guideline and outcomes among patients whose underlying comorbidities present a risk of fluid overload.
METHODS: Our search was conducted on PubMed and Scopus through November 5, 2021 to identify studies that evaluated clinical outcomes among septic patients with CHF/ESRD based on volume of fluid administered. The primary outcome measured was mortality at 30 days post-hospital discharge. Other outcomes included the rates of vasopressor requirements, invasive mechanical ventilation during hospitalization, as well as length of stay in the intensive care unit and/or hospital. We used random effects meta-analysis when two or more studies reported the same outcome.
RESULTS: We included five studies in the final meta-analysis, which comprised 5804 patients, 5260 (91%) of whom received non-aggressive fluid resuscitation, as defined by the studies' authors. Random-effects meta-analysis for all-cause mortality showed that aggressive fluid resuscitation was associated with statistically non-significant increased odds of mortality (OR 1.42, 95% CI 0.88-2.3, P = 0.15, I2 = 35%). There was no statistical association between volume of IVF administration and other outcomes evaluated.
CONCLUSION: Among septic shock patients with CHF and/or ESRD, administration of greater than or equal to 30 ml/kg IVF was associated with a non-significant increase in odds of mortality. All other outcomes measured were found to be non-significant, although there was a trend toward better outcomes among patients in the restricted-volume compared to the standard-volume IVF groups. Since this meta-analysis only included five observational studies, more studies are needed to guide an optimal volume and rate of fluid administration in this patient population.
参考来源
- Pence M, Tran QK, Shesser R, et al. Outcomes of CMS-mandated fluid administration among fluid-overloaded patients with sepsis: A systematic review and meta-analysis. Am J Emerg Med. 2022. PMID: 35338881. doi:10.1016/j.ajem.2022.03.004
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。